The hemostasis analyzers market is projected to reach US$ 6,490.24 million by 2028 from US$ 3,440.66 million in 2021; it is expected to register a CAGR of 9.5% from 2021 to 2028. Based on product type, the hemostasis analyzers market is segmented into facial laboratory analyzers and point-of-care testing systems. The laboratory analyzer segment held a larger market share in 2021, and it is...